TP53 mutation	Triple Negative Breast Cancer	TP53 mutation	Triple Negative Breast Cancer	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D
TP53 mutation	HER2 Positive Breast Cancer	TP53 mutation	HER2 Positive Breast Cancer	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D
TP53 mutation	Glioblastoma	TP53 mutation	Glioblastoma	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D
DDR	Triple Negative Breast Cancer	DDR	Triple Negative Breast Cancer	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D	AZD1390 Sensitive: D – Preclinical AZD1390 Sensitive : D

AZD1390

Associations
(5)